Perspective: Understanding COVID-19 vaccine efficacy
In this Perspective, Marc Lipsitch and Natalie Dean consider what would happen if a COVID-19 vaccine offers little to no protection in high-risk groups, like the elderly and those with comorbidities, yet is able to reduce infection or infectiousness in younger adults. In such a case, they say, an indirect protection strategy – whereby those…